MedTrace Logo

Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)

NCT04053647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2020-08-07

No results posted yet for this study

Summary

Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. The hypothesis of the investigators is that the mental health is impaired in hypoparathyroid patients compared with thyroidectomized patients without hypoparathyroidism. The investigators evaluated the quality of life using the SF-36 survey in comparison with a control population of patients thyroidectomized but free from this complication. The voice quality, the cardiovascular risk, the kidney function and the incidence of urinary lithiasis were also evaluated.

Conditions

  • Hypoparathyroidism
  • Quality of Life

Interventions

OTHER

Non-interventional study

Non-interventional study

Sponsors & Collaborators

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Centre Hospitalier le Mans

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • Central Hospital, Nancy, France

    collaborator OTHER

  • Pitié-Salpêtrière Hospital

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2020-06-24
Completion
2020-06-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04053647 on ClinicalTrials.gov